Beactica Therapeutics

Beactica Therapeutics is a specialist drug discovery and development company, committed to the fight against cancer. Beactica is advancing a proprietary pipeline of first-in-class therapeutics by applying its molecular interaction-based drug discovery engine synergistically across multiple small molecule modalities including allosteric modulators, proteinprotein interaction inhibitors and targeted protein degraders (PROTACs)

Surface plasmon resonance (spr),fragment-based drug discovery,interaction analysis,kinetics,mechanism of action,oncology,protacs,allosteric modulators,therapeutics,and drug discovery

Beactica therapeutics operates in the Pharmaceutical manufacturing industry.

Beactica therapeutics's revenue is 11m - 100m

Beactica therapeutics has 11 - 50 employees.